Medtronic revenue and financials

MDT · NYSE · USD

$87.09Change from previous close: −1.00%Absolute change: −$0.88

Close · October 6, 2026

In the fiscal year ended April 2026, Medtronic reported revenue of $36.36B (+8.43% year over year). Net income was $4.8B, a net margin of 13.2%.

Annual revenue · 2026: $36.36B
  1. $29.71B2017
  2. $29.95B2018
  3. $30.56B2019
  4. $28.91B2020
  5. $30.12B2021
  6. $31.69B2022
  7. $31.23B2023
  8. $32.36B2024
  9. $33.54B2025
  10. $36.36B2026

Fiscal year ending in April. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+8.43%
FY to Apr 2026 vs FY to Apr 2025
Net income growth
+2.98%
FY to Apr 2026 vs FY to Apr 2025
Net margin
13.2%
FY to Apr 2025: 13.9%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ to Jul 2026Q to Apr 2026Q to Jan 2026Q to Oct 2025Q to Jul 2025Q to Apr 2025Q to Jan 2025Q to Oct 2024Q to Jul 2024Q to Apr 2024Q to Jan 2024Q to Oct 2023
Operating cash flow1,7932,5732,7449251,0882,5282,5729589862,7772,474661
Depreciation and amortization729716719699703689684675662654649672
Capital expenditure-503-488-444-468-504-459-476-404-520-426-346-461
Investing cash flow-1,619-917-816-482-719-490-843-345-259-696-707-424
Financing cash flow-343-888-2,087-395-1,381-1,343-1,753-534-731-2,359-1,500-90.0
Dividends paid-921-908-911-910-910-897-897-897-898-913-917-918
Share repurchases-267-435-105-372-123-274-181-288-2,492-1,628-132-226
Debt issued812-164-1,2292,500649———3,20963.0-311821
Debt repaid0.0——-1,768-1,162—-1,003557-624———
Effect of exchange rates-89.033.024.0-39.067.0283-1304.031.0-60.044.0-175
Net change in cash-258802-1359.0-945978-15483.027.0-339312-28.0
Free cash flow1,2902,0852,3004575842,0692,0965544662,3512,128200
Levered free cash flow1,0012,0532,1542842131,4581,93271342.32,3541,826639